HumanaHUM
Market Cap: $43.1B
About: Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Employees: 67,600
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
33% more funds holding in top 10
Funds holding in top 10: 18 [Q1] → 24 (+6) [Q2]
19% more call options, than puts
Call options by funds: $1.83B | Put options by funds: $1.55B
11% more capital invested
Capital invested by funds: $38.1B [Q1] → $42.5B (+$4.37B) [Q2]
3.21% more ownership
Funds ownership: 91.11% [Q1] → 94.32% (+3.21%) [Q2]
5% less funds holding
Funds holding: 1,001 [Q1] → 950 (-51) [Q2]
13% less repeat investments, than reductions
Existing positions increased: 329 | Existing positions reduced: 377
30% less first-time investments, than exits
New positions opened: 121 | Existing positions closed: 172
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
RBC Capital Ben Hendrix 80% 1-year accuracy 47 / 59 met price target | 12%upside $400 | Outperform Maintained | 5 Sept 2024 |
JP Morgan Lisa Gill 67% 1-year accuracy 16 / 24 met price target | 11%upside $396 | Neutral Maintained | 21 Aug 2024 |
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target | 10%upside $395 | Neutral Reiterated | 19 Aug 2024 |
Deutsche Bank George Hill 100% 1-year accuracy 6 / 6 met price target | 2%downside $349 | Hold Maintained | 2 Aug 2024 |
Oppenheimer Michael Wiederhorn 76% 1-year accuracy 25 / 33 met price target | 12%upside $400 | Outperform Maintained | 1 Aug 2024 |
Financial journalist opinion
Based on 9 articles about HUM published over the past 30 days